Core-shell microneedle devices and uses thereof
Abstract:
The present disclosure relates to microneedle devices and methods for treating a disease (for example, diabetes) using a degradable cross-linked gel for self-regulated delivery of a therapeutic agent (for example, insulin).
Public/Granted literature
Information query
Patent Agency Ranking
0/0